← Browse by Condition
Medical Condition
neoplasm metastasis
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2
NCT05573893
Recruiting
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan
Enrollment
800 pts
Location
Germany
Sponsor
AstraZeneca
NCT07114601 Phase 1
Recruiting
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Enrollment
421 pts
Location
United States, Canad...
Sponsor
Eli Lilly and Company
NCT06046131
Recruiting
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
Enrollment
3,000 pts
Location
France, Guadeloupe
Sponsor
Centre Hospitalier Universitai...
NCT06532539 Phase 2
Recruiting
Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma
Enrollment
30 pts
Location
China
Sponsor
Shandong Cancer Hospital and I...